Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Director departure
CC transcript
CALLISTO PHARMACEUTICALS INC (CLSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/15/2013 8-K Quarterly results
01/03/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release"
10/16/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amendment No. 1 to the Agreement and Plan of Merger, by and among Synergy Pharmaceuticals Inc. and Callisto Pharmaceuticals, Inc"
07/23/2012 8-K Form 8-K - Current report
04/19/2011 8-K Form 8-K - Current report
12/16/2010 8-K Form 8-K - Current report
05/27/2010 8-K Form 8-K - Current report
03/24/2010 8-K/A Form 8-K - Current report [amend]
03/23/2010 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Request for Extension",
"Form of Extension Agreement"
09/22/2009 8-K Form 8-K - Current report
06/24/2009 8-K Form 8-K - Current report
12/31/2008 8-K Form 8-K -- Current report
12/23/2008 8-K Entry into a Material Definitive Agreement
07/18/2008 8-K Form 8-K -- Current report
07/14/2008 8-K Resignation/termination of a director
07/08/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
04/11/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -"
04/07/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Callisto Pharmaceuticals Files IND for SP-304 in Chronic Constipation and Irritable Bowel Syndrome"
01/07/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme New Agreement Eliminates Development Milestones and Significantly Reduces Royalties in Return for an Upfront Fee"
12/21/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter to stockholders of Callisto Pharmaceuticals, Inc"
12/12/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
10/11/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Callisto Pharmaceuticals, Inc. investor presentation materials to be used by the Company's executive officers at meetings with investors, stockholders and analysts and at investor conferences beginning on or after October 11, 2007, and to be used from time to time thereafter"
10/01/2007 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial ...
Docs: "Certificate of Amendment to Certificate of Incorporation of Callisto Pharmaceuticals, Inc",
"Form of Common Stock Purchase Warrant to purchase 1,150,000 shares of common stock of Callisto Pharmaceuticals, Inc"
08/30/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release of Callisto Pharmaceuticals, Inc."
08/21/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
08/07/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "Certificate of Designations, Number, Voting Powers, Preferences and Rights of Series B Convertible Preferred Stock of Callisto Pharmaceuticals, Inc",
"Certificate of Amendment to Certificate of Designations, Number, Voting Powers, Preferences and Rights of Series A Convertible Preferred Stock of Callisto Pharmaceuticals, Inc",
"Form of Warrant to purchase shares of Common Stock issued in connection with the sale of the Series B Convertible Preferred Stock",
"Form of Securities Purchase Agreement by and among Callisto Pharmaceuticals, Inc. and the purchasers set forth on the signature page thereto",
"Form of Registration Rights Agreement by and among Callisto Pharmaceuticals, Inc. and the purchasers signatory thereto",
"Form of Put Option Agreement between Callisto Pharmaceuticals, Inc. and the purchasers signatory thereto",
"Press Release of Callisto Pharmaceuticals, Inc."
06/22/2007 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Callisto Pharmaceuticals, Inc. Receives Notice From AMEX"
06/08/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversion and Related Claims"
06/04/2007 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws of Callisto Pharmaceuticals, Inc"
02/20/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
01/30/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
01/26/2007 8-K Entry into a Material Definitive Agreement
01/17/2007 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Securities Purchase Agreement by and among Callisto Pharmaceuticals, Inc. and the purchasers set forth on the signature page thereto"
01/04/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Callisto Pharmaceuticals CEO Releases Letter to Shareholders Describing Recent Accomplishments"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy